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NMR-based assignment of isoleucine vs. allo-
isoleucine stereochemistry†
Zoe J. Anderson, Christian Hobson, Rebecca Needley, Lijiang Song,
Michael S. Perryman, Paul Kerby and David J. Fox *
A simple 1H and 13C NMR spectrometric analysis is demonstrated that permits diﬀerentiation of isoleucine
and allo-isoleucine residues by inspection of the chemical shift and coupling constants of the signals
associated with the proton and carbon at the α-stereocentre. This is applied to the estimation of epimeri-
sation during metal-free N-arylation and peptide coupling reactions.
Introduction
The assignment of the relative stereochemistry of amino-acid
residues within complex natural products is normally achieved
by degradation of the product to its constituent fragments, fol-
lowed by reaction with a chiral derivatising agent, commonly
Marfey’s reagent.1 During peptide coupling, epimerisation is
usually measured by HPLC separation of the diastereoisomeric
products.2 1H, 13C and 15N NMR spectrometry can also be
used to calculate the level of epimerisation, either via chiral
derivatisation or with a chiral shift reagent.3 Recently, during
the structural assignment4 and synthesis5 of the azolemycins,
we noted that the 1H NMR spectrum of the isoleucine portion
of the natural product was significantly diﬀerent from its allo-
isoleucine diastereoisomer.
L-Isoleucine is one of the common amino-acids found in
eukaryotic and prokaryotic proteins,6 but is unusual in that it
possesses two stereogenic centres. It can therefore exist as four
distinct stereoisomers (Fig. 1).7 Epimerisation at the α-centre
can occur due to resonance stabilisation and electron-with-
drawing eﬀects from the amino- and carboxy-groups to give
D-allo-isoleucine. In contrast, the β-centre is distanced from
these eﬀects and so is much more diﬃcult to epimerise to give
the less common L-allo-isoleucine stereoisomer.7a,8 This lack
of reactivity allows the β-configuration at the carbon to act as a
marker for epimerisation at the α-carbon. Isoleucine as a
marker for the study of racemisation during peptide synthesis
has been known for a number of years,9 but the final assess-
ment of chiral purity is usually performed by hydrolysis fol-
lowed by analytical chromatography.10
To our knowledge, only two reports exist describing the
specific diﬀerentiation of L-isoleucine and D-allo-isoleucine by
1H NMR spectrometry. In 1983, Khatskevich et al. reported
that both the chemical shift and the coupling constants for
the hydrogen at the α-carbon diﬀered for N-benzoyl-L-isoleu-
cine methyl ester and N-benzoyl-D-allo-isoleucine methyl ester
((2S,3S) diastereoisomer, δH ppm 4.70, dd,
3JCH–CH 5.15 Hz),
3JCH–NH 8.62 Hz; ((2R,3S) diastereoisomer, δH ppm 4.90, dd,
3JCH–CH 4.30 Hz,
3JCH–NH 9.0 Hz).
11 Similarly, in 2003 Biron and
Kessler noted that, when hydrolysing Nα-methyl-Nα-o-NBS-L-
isoleucine methyl ester, epimerisation at the α-stereocentre
could be observed by the appearance of a new peak (corres-
ponding to the D-allo-isoleucine stereoisomer α-CH) downfield
from the usual peak observed for the L-isoleucine-derived
stereoisomers.12 During the course of our studies into peptide
bond synthesis, we decided to use this diﬀerence between
L-isoleucine and its epimer, D-allo-isoleucine by 1H NMR
spectrometry to easily assess the comparative levels of epimeri-
sation during a range of reactions of molecules with a
C-terminal L-isoleucine residue.
A range of C- and N-substituted isoleucine-containing mole-
cules were synthesised using pure L-isoleucine and then
repeated for comparison with a mixture of L-isoleucine and
D-allo-isoleucine by standard methods (Fig. 2, see ESI† for
details). N-Undec-10-enoyl 5a and N-benzoyl-L-isoleucine 6a
were epimerised to a mixture of L-isoleucine and D-allo-isoleu-
cine derivatives using the method of du Vigneaud et al.13
Compounds lacking an N-terminal acyl group were synthesised
Fig. 1 Isoleucine and allo-isoleucine stereochemistry.
†Electronic supplementary information (ESI) available: Synthesis details, NMR
spectra and chiral HPLC chromatograms. See DOI: 10.1039/c7ob01995e
Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry,
CV4 7AL, UK. E-mail: d.j.fox@warwick.ac.uk
9372 | Org. Biomol. Chem., 2017, 15, 9372–9378 This journal is © The Royal Society of Chemistry 2017
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
N
ov
em
be
r 2
01
7.
 D
ow
nl
oa
de
d 
on
 2
8/
03
/2
01
8 
16
:1
9:
38
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View Issue
from an epimeric mixture of D-allo-isoleucine and L-isoleucine,
prepared from L-isoleucine according to the method of
Yamada et al.14 In addition, a model dipeptide octanoyl-glycyl-
isoleucine was prepared as both the methyl ester 9 and the
acid 10, again diastereoisomerically pure and as a mixture
(Scheme 1).
For the isoleucine derivatives 2 to 7, diﬀerences of
L-isoleucine and D-allo-isoleucine stereochemistry due to epi-
merisation were readily observed by the appearance of a new
peak, assignable as the proton at the α-stereocentre of D-allo-
isoleucine by comparison with the equivalent compound pre-
pared from a diastereoisomeric mixture of amino-acids.
Compounds 5 and 10 were coupled to fluorenylmethane thiol
11 according to the method of Crich et al.,15 to give the corres-
ponding thioesters 12 and 13 respectively (Scheme 2). In each
case, considerable epimerisation at the L-isoleucine stereocen-
tre of the products 12a and 13a was readily identified by the
appearance of a new peak in the 1H NMR spectrum, assignable
as the proton at the α-stereocentre of D-allo-isoleucine, by com-
parison with the equivalent products 12b and 13b prepared
from the diastereoisomeric mixtures 5b and 10b. N-Propyl
amides 15 and 16 were prepared by deprotection of the thio-
esters and reaction with the sulphonamide of propylamine 14.
In each case, the products were obtained as a mixture of dia-
stereoisomers in roughly the same proportions as the starting
materials. Again, it was possible to distinguish between the
L-isoleucine and D-allo-isoleucine derivatives by 1H NMR spec-
trometry (Scheme 3). For comparison, both 15 and 16 were
also prepared using a direct PyBOP mediated peptide coupling
reaction between propylamine and the equivalent acids 5a and
10a (not shown, see ESI†).
The 1H NMR spectra of the isoleucine derivatives were
recorded in CDCl3, CD3OD and (CD3)2SO, both as a mixture of
diastereoisomers and, where possible, as the single diastereo-
isomer (Tables 1–3). 700 MHz 1H NMR spectra were obtained
and, after calibration against the internal solvent peak, the
chemical shifts and coupling constants for the α-CH hydrogen
were measured. 13C NMR spectra were also obtained for most
of these compounds at 100 MHz in CDCl3 only. The
13C chemi-
cal shifts corresponding to the α-CH were measured (Table 1).
The general trends noted earlier were further supported by
these results. In all cases we found that the α-CH chemical
shift for the D-allo-isoleucine diastereoisomer occurs at a
higher chemical shift than that for the L-isoleucine diastereo-
isomer. In addition, the 3JCH–CH coupling constants for the
L-isoleucine diastereoisomer α-CH are always larger, and the
Fig. 2 Isoleucine derivatives prepared wth L-isoleucine and a mixture of
L-isoleucine and D-allo-isoleucine stereochemistry.
Scheme 1 Reagents and conditions: (i) EDCI, HOBt, NMM, EtOH, 0 °C
to rt, 17 h; (ii) LiOH, THF, H2O, 0 °C, 4 h.
Scheme 2 Reagents and conditions: (i) 11, PyBOP, iPr2NEt CH2Cl2,
−20 °C, 4 h.
Scheme 3 Reagents and conditions: (i) Piperidine, DMF, rt, 1.5 h; (ii)
Cs2CO3, DMF, 14, rt, 1 h.
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3JCH–NH coupling constants are usually smaller, than those for
the D-allo-isoleucine diastereoisomer.
Generally, the diﬀerence in chemical shifts corresponding
to the α-CH of L-isoleucine and D-allo-isoleucine was greatest
in DMSO-d6 and smallest in CDCl3, but the α-CH 1H NMR
peaks were always suﬃciently distinct not to overlap at both
700 MHz and 400 MHz. This suggests they would be suitable
for the approximate assignment of relative stereochemistry of
isoleucine residues in compounds with unknown relative
stereochemistry. The 13C NMR data also suggest a useful trend
with the chemical shift corresponding to the α-C ̲H of the D-
allo-isoleucine derivative always occurring at a lower chemical
shift than that for the L-isoleucine derivative, in most cases by
more than 1 ppm. Taken in conjunction with the 1H NMR
data, the 13C NMR data are also likely to prove extremely useful
for the approximate assignment of relative stereochemistry of
isoleucine residues in novel natural products.
N-Arylation and peptide coupling
reactions
N-Heteroaryl-amine derivatives, including N-aryl-α-amino-acid
derivatives, provide important building blocks for a number of
biologically active products.16 We considered whether the
NMR-based trends described above for distinguishing L-iso-
and D-allo-isoleucine derivatives would apply to N-aryl com-
pounds. A range of methods for N-arylation have been
described, including the use of copper, palladium and nickel
catalysis.16e,17 N-Arylations of chiral amino-acids have been
reported,17c,18 and while some methods involve harsh con-
ditions that risk racemisation, other methods are much milder
and can occur without loss of stereochemical integrity as part
of amino-acid analysis.19
To test these methods L-isoleucine methyl ester hydro-
chloride 2a was heteroarylated with four imidoylchloride-like
aryl chlorides in metal free conditions (Table 4). As expected
in the mildly basic reaction conditions, 1H NMR analysis indi-
cated that arylations proceeded without significant epimerisa-
tion (17a–20a) when compared to reactions of a diastereoiso-
meric mixture of L-iso- and D-alloisoleucine methyl esters 17b–
20b (not drawn, see ESI†). The product ratios measured by 1H
NMR were confirmed by HPLC. Peptide couplings of
N-arylated amino-acids have been used in the synthesis of a
variety of peptidomimetic molecules, including DNA topo-
isomerases,20 cathepsin S. inhibitors,21 and benzoxaborales.22
We decided to extend the current study to include the syn-
thesis of two N-aryl isoleucylglycine methyl esters, as well as
the related N-benzoyl and N-tosyldipeptides for comparison.
N-Aryl methyl esters 18a and 20a were hydrolysed and coupled
to glycine methyl ester without isolation of the acids. Acids 4a
and 6a were coupled directly (Table 5). Dipeptides 21a–23a
were produced as essentially single diastereoisomers, by com-
parison by both NMR spectrometry and HPLC with authentic
stereoisomeric mixture 21b–24b (not drawn, see ESI†). The
N-benzoyl product 24a was produced as a near equal mixture
Table 1 Chemical shifts and coupling constants of L-isoleucine and
D-allo-isoleucine diastereoisomers 3 to 16
Entry
α-CH ̲ (ppm)
3JCH–CH
a
(Hz)
3JCH–NH
a
(Hz) α-C̲H (ppm)
L D-allo L D-allo L D-allo L D-allo
3 3.80 3.90 5.5 4.0 10.0 10.0 60.2 59.0
4 3.87 3.99 4.9 3.3 9.5 9.9 59.9 58.6
5 4.62 4.75 5.1 4.0 8.0 8.6 56.5 55.2
6 4.86 4.98 4.9 3.9 8.1 8.5 57.0 55.7
7 4.84 4.95 5.2 4.0 8.4 8.8 56.8 55.8
9 4.54 4.65 5.3 4.1 8.4 8.8 56.7 55.6
10 4.53 4.69 5.3 4.5 7.5 8.5 56.9 n/a
12 4.63 4.76 5.1 4.0 8.2 9.1 63.2 61.8
13 4.53 4.66 4.8 4.0 8.8 8.8 63.8 62.3
15 4.21 4.32 7.9 6.6 7.9 8.4 57.5 57.0
16 4.34 4.45 7.5 5.7 7.5 8.8 56.7 55.6
a To the nearest 0.1 Hz.
Table 2 Chemical shifts and coupling constants of L-isoleucine and
D-allo-isoleucine diastereoisomers 2 to 16 in CD3OD
Entry
α-CH̲ (ppm) 3JCH–CHa (Hz)
L D-allo L D-allo
2 4.00 4.03 4.0 3.9
3 3.70 3.82 7.0 5.0
4 3.67 3.82 5.5 4.5
5 4.37 4.54 5.8 4.7
6 4.57 4.74 6.4 5.0
7 4.56 4.74 6.9 5.6
9 4.42 4.56 6.0 4.4
10 4.40 4.55 5.3 4.0
12 4.31 4.48 6.1 5.1
13 4.33 4.48 5.7 4.8
15 4.15 4.31 8.3 6.7
16 4.20 4.35 7.5 5.7
a To the nearest 0.1 Hz.
Table 3 Chemical shifts and coupling constants of L-isoleucine dia-
stereoisomers and D-allo-isoleucine diastereoisomers 1–16 in (CD3)2SO
Entry
α-CH̲ (ppm) 3JCH–CHa (Hz) 3JCH–NHa (Hz)
L D-allo L D-allo L D-allo
1 3.05 3.08 3.2 2.9 b b
2 3.91 3.92 4.2 3.8 b b
3 3.54 3.69 7.5 6.0 9.0 10.0
4 3.52 3.67 6.0 4.5 9.0 9.5
5 4.17 4.35 6.5 5.0 8.1 8.5
6 4.33 4.53 7.6 5.8 7.6 8.5
7 4.36 4.55 7.7 6.4 7.7 8.0
9 4.23 4.39 6.6 5.1 8.4 8.6
10 4.19 4.36 5.9 4.4 8.6 8.8
12 4.15 4.33 7.4 5.1 7.4 8.7
13 4.15 4.33 6.2 5.1 8.4 8.6
15 4.10 4.25 8.5 6.3 8.5 9.0
16 4.12 4.25 7.5 5.7 8.8 9.2
a To the nearest 0.1 Hz. bNot measurable.
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of diastereoisomers. While it is well known that N-benzoyl
amino acids tend to racemise during standard peptide coup-
ling reactions,23 and that N-sulfonyl amino acids do not,24 to
the best of our knowledge, there is little quantitative infor-
mation regarding the levels of epimerisation of the C-terminal
N-arylated amino-acids during these peptide coupling reac-
tions. There are two main mechanisms of epimerisation
during peptide coupling reactions, deprotonation of the
α-carbon and 5(4H)-oxazolone formation.9c In practise, these
are normally minimised by careful control of reaction tempera-
ture, pH and N-substituent on the C-terminal amino-acid.
Generally, N-amido amino-acids are more prone to racemisa-
tion than N-carbamate amino-acids (e.g. N-Cbz, N-Boc or
N-Fmoc amino acids) having a greater tendency to oxazolone
formation.9c,25 Despite this, the benzoxazole and triazine active
esters do not epimerise during peptide coupling via the related
imidazolinone even though the heterocyclic nitrogens are in an
analogous position to that of the amide oxygen in the benz-
amide (Scheme 4). Such a diﬀerence may be due to reduced
nitrogen nucleophilicity because of increased steric crowding
compared to the amide. Relative basicity does not correlate with
nucleophilicity in this case as, even though 2-amino-4,6-
dimethoxy-s-triazine is a very weak base in water,26 2-amino-
benzoxazole has a pKaH(H2O) of 3.73,
27 and is therefore signifi-
cantly more basic than benzamide (pKaH(H2O) = −1.53).28
Analysis of the 1H NMR and 13C NMR data for the N-aryl
esters and the dipeptides show that the trends in relative
chemical shift and coupling constants for the (2S,3S)- and
Table 4 N-Arylation reactions of isoleucine methyl ester
Product Heterocycle Yield % (2S,3S) : (2R,3S) by NMR (2S,3S) : (2R,3S) by HPLC
17a 55a >95 : 5 >99 : 1
18a 30b >95 : 5 99 : 1
19a 33b >95 : 5 >99 : 1
20a 36b >95 : 5 >99 : 1
aMicrowave, 80 °C, sealed tube, 2 h. b 20 °C, 1 atm, 12 h.
Table 5 Peptide coupling reactions of N-arylated isoleucine derivatives
Entry R Yield
(2S,3S) : (2R,3S)
by NMR
(2S,3S) : (2R,3S)
by HPLC
21a 50% >95 : 5 >99 : 1
22a 76% 97 : 3 >97 : 3
23a 84% >95 : 5 >99 : 1
24a 54% 44 : 56 Not measured
Reagents (i) LiOH H2O, THF then EDCI, HOBt, NMM, EtOH, 0 °C to rt,
17 h.
Scheme 4 Potential racemization mechanism of N-imidoyl amino-
acids during peptide coupling.
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(2R,3S)-diastereoisomers described above apply to these
compounds as well (Table 6).
While L-isoleucine is the most common diastereoisomer in
natural products, D-allo-isoleucine is also fairly common in
microbial peptides, including the sporidemolides, stendomy-
cin, angolide, actinomycin C, calpinactam and peptidolipin N.
A.29 In addition, D-allo-isoleucine has been identified in pep-
tides isolated from the skin of the yellow bellied toad, Bombina
variegate.30 Unsurprisingly, considering the comparative stabi-
lity of the β-CH̲ of isoleucine peptides containing L-allo-isoleu-
cine and D-isoleucine are far less common, though a few
examples do exist.31 Alteration of relative stereochemistry of
isoleucine within a peptide can have significant eﬀects of its
structure and folding, and potentially its biological activi-
ty.31d,32 The ability to distinguish between, and potentially
predict, the stereochemistry isoleucine diastereoisomers by a
non-destructive method such as NMR, instead of peptide
hydrolysis, is valuable, particularly for complex natural
proteins, which are often only obtained in minute quantities.
While in this study we cannot distinguish between L-allo-
isoleucine and D-allo-isoleucine, and between the L- and
D-isoleucine, the comparative rarity of the D- and L-allo forms
means that this method will prove extremely useful. This
method can be applied to the structure of the antibiotic
peptide teixobactin.33 By hydrolysis, and derivatisation using
Marfey’s method, teixobactin was found to contain three
L-isoleucines and one D-allo-isoleucine. It is worth noting that
the full assignments of the NMR spectra of the peptide in
deuteriated DMSO show that in the 1H NMR spectrum the
peak corresponding to the α-CH hydrogen of the D-allo-
isoleucine residue has a higher chemical shift (4.36 ppm) than
the peaks due to the α-CH hydrogens of the three L-isoleucine
residues (4.29, 4.12 and 4.03 ppm), and that in the 13C NMR
spectrum the peak corresponding to the α-CH carbon of the
D-allo-isoleucine has a lower chemical shift (56.8 ppm) than
those corresponding to α-CH carbons of the three L-isoleucine
residues (57.3, 57.8 and 57.9 ppm), in agreement with the
trends observed in Tables 1–3 and 6.
It is unclear at this point as to whether the diﬀerences
observed are due to purely stereochemical diﬀerences in
amino-acid derivatives with otherwise similar backbone con-
formations, or if the stereochemical diﬀerences cause a signifi-
cant change in backbone conformation which is itself the
reason for the observed diﬀerences in the NMR spectra.34
Diﬀerentiation between these two possibilities may be eﬀected
by studying pairs of stereoisomers with defined conformations
e.g. involving cyclic peptides of various sizes. Conformational
analysis would be supported with molecular modelling. While
the analysis of the spectra from teixobactin,33 which contains
both linear and cyclic isoleucine-containing regions, indicates
that the trends presented in this paper may be applicable to
more complex peptides, the issues of conformation and
additional stereochemistry are the subjects of future work in
our laboratory and results will be reported in due course.
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